  
<prompt> National-Level Trends in IPTp 2+
 Percent of women age 15-49 with a live birth in the past two years who, during their last pregnancy, received atleast 2 or more doses of SP/Fansidar who received atleast one dose during an antenatal care visit. 
 [["EDSB-III 2006", 3], ["EDSB-IV 2011-2012", 23], ["EDSB-V 2017-2018", 33]] 
 <response> One-third of women age 15-49 who had a live birth in the two years before the survey (33%) received two or more doses of SP/Fansidar, at least one during an antenatal visit. IPTp 2+ increased significantly from 3% in 2006 to 23% in 2011-2012 to 33% in 2017-2018.  